A randomized, phase 3, double-blind trial examining methotrexate and etanercept as monotherapy or in combinstion for treating psoriatic arthritis: A comparison of the composite measures used to evaluate disease activity

Ítems similars

• Performance of composite measures used in a trial of etanercept and methotrexate as monotherapy or in combination in psoriatic arthritis
  per: Coates, L, et al.
  Publicat: (2020)
• Design and rationale of the Study of Etanercept and Methotrexate in Combination or as Monotherapy in Subjects with Psoriatic Arthritis (SEAM-PsA)
  per: Mease, P, et al.
  Publicat: (2018)
• Patient-reported outcomes data in patients with psoriatic arthritis from a randomised trial of etanercept and methotrexate as monotherapy or in combination
  per: Vibeke Strand, et al.
  Publicat: (2021-04-01)
• Impact of clinical domains other than arthritis on composite outcomes in psoriatic arthritis: comparison of treatment effects in the SEAM-PsA trial
  per: Helliwell, PS, et al.
  Publicat: (2022)
• Methotrexate in psoriasis and psoriatic arthritis
  per: Coates, L, et al.
  Publicat: (2020)